author-photo

Tobias Litzenburger

Boehringer Ingelheim

17

Papers

666

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Basophil activation test: Assay precision and BI 1002494 SYK inhibition in healthy and mild asthmatics.

2021 Cytometry Part A
Show All
- Source
- Cite
- Save
Citations (1)
Safety, pharmacokinetics and pharmacodynamics of BI 705564, a highly selective, covalent inhibitor of Bruton's tyrosine kinase, in Phase I clinical trials in healthy volunteers

2020 British Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (3)
Boosting antibody developability through rational sequence optimization

2015 mAbs
Show All
- Source
- Cite
- Save
Citations (44)
EVALUATION OF A SPECIFIC ANTIDOTE TO DABIGATRAN: IN VITRO PROPERTIES, PHARMACOKINETICS AND REVERSAL OF DABIGATRAN ETEXILATE–INDUCED BLEEDING IN RATS

2013 Journal of the American College of Cardiology
Show All
- Source
- Cite
- Save
Citations (3)
A specific antidote for dabigatran: functional and structural characterization

2013 Blood
Show All
- Source
- Cite
- Save
Citations (479)
Reversal of dabigatran clotting activity in the rat ex vivo by a specific and selective antibody fragment antidote: are there non-specific effects on warfarin, rivaroxaban and apixaban?

2013 European Heart Journal
Show All
- Source
- Cite
- Save
Citations (1)
Abstract WP261: In Vitro Characterization, Pharmacokinetics and Reversal of Supratherapeutic Doses of Dabigatran-Induced Bleeding in Rats by a Specific Antibody Fragment Antidote to Dabigatran

2013 Stroke
Show All
- Source
- Cite
- Save
Citations (8)
In Vitro Characterization, Pharmacokinetics and Reversal of Supratherapeutic Doses of Dabigatran-Induced Bleeding in Rats by a Specific Antibody Fragment Antidote to Dabigatran

2012 Blood
Show All
- Source
- Cite
- Save
Citations (23)
Anti-CD40-Antikörper

2011
Show All
- Source
- Cite
- Save
Citations (0)
Remedy for anticoagulant.

2011
Show All
- Source
- Cite
- Save
Citations (0)